Globally, only 21% of countries are currently using appropriate levels of Factor VIII treatment in the management of hemophilia.
Atlanta, Georgia (PRWEB) November 21, 2014
Innovaacom, L.L.C., today announced the results of a medical education program held in Zurich, Switzerland designed to help physicians enhance communications around the importance of better treatment protocols for patients with hemophilia, an inherited bleeding disorder which has no cure. The Innovaacom continuing education program was attended by physicians from Spain, Portugal, Germany, India, Italy, Algeria, Serbia, Argentina, Hungary, Brazil, Lebanon and Japan.
Hemophilia impacts about 2% of the worldwide population and is a medical condition in which a patient’s blood doesn't clot normally because it lacks sufficient blood-clotting proteins. Patients with hemophilia typically lack sufficient levels of Factor VIII, which helps the blood to clot, causing the sufferer to bleed severely and sometimes even die from minor cuts and injuries. Globally, only 21% of countries are currently using appropriate levels of Factor VIII treatment in the management of hemophilia. Without adequate treatment, many people with hemophilia die before they reach adulthood. However, with proper treatment, children diagnosed with the disease can look forward to a normal life expectancy.
Innovaacom brought together a panel of global experts in hemophilia to talk about establishing universal treatment protocols across the world to enable physicians to master care management of patients with hemophilia. The Innovaacom program also gave physicians tools and techniques for writing medical manuscripts and abstracts related to the subject as well as public speaking pointers to share their personal experiences and case study findings across the globe. “We all have our books, internet websites and recommendations where we can find information but the interaction with experts here at the program, sharing of experiences, and examples creates a valuable dialogue that can be immediately applied to our everyday practice,” shared one doctor.
Innovaacom is a global company that provides medical education and training for physicians and pharmacists around the world. To date, Innovaacom has trained more than 7,000 healthcare providers. Post-program satisfaction survey results report that 94% of attendees feel more confident in their ability to provide appropriate care for patients with hemophilia and to write evidence-based manuscripts or give public presentations about hemophilia disease management.
About Innovaacom, L.L.C.
Founded in 2007, Innovaacom is a global agency providing medical education and training for healthcare professionals worldwide that applies globally and empowers locally. Innovaacom courses combine science with leadership and communications skills training that helps translate the latest scientific and medical innovation into real clinical practice. Program design and delivery includes CME and non-CME training